Friday, September 4, 2026

Coronavirus Pandemic Will Weed Out Many Zombie Companies: eParkio Co-Founder

Elham P.Mohammadi

May 15, 2020

Rob Kramer, co-founder at eParkio, says the COVID-19 crisis will lead to the death of zombie companies. (Photo credit: eParkio)

For years, experts have been warning that the increasing number of companies relying on debt to stay afloat poses a serious threat to the global economy. 

Most economists agree that the proliferation of these "zombie" firms, which are basically on life support, makes it more difficult for profitable companies to grow as they drain capital and human resources, reduce productivity, distort competition, and hamper growth.

Rob Kramer, CEO and co-founder at eParkio, believes one good thing that could come out of the COVID-19 crisis is the death of an army of half-dead companies, which are unable to finance their debts with current earnings for an extended period.

"On a positive note, I think it's gonna weed out a lot of the zombie companies that are currently living off just the money that they had raised," Rob told Via News in an interview when asked about the impact of the coronavirus outbreak on the startup ecosystem in Europe.

eParkio is a European marketplace that links drivers with parking spaces. (Photo credit: eParkio)
eParkio is a European marketplace that links drivers with parking spaces. (Photo credit: eParkio)

His startup—which is Europe's 1st continent-wide parking marketplace connecting drivers with parking spaces in real-time—has not been left unscathed by movement restrictions aimed at stopping the spread of the deadly respiratory disease.

"Since we're in the mobility industry, our revenue is coming from people driving. So… it was clear to us that our revenue will decline once the lockdown comes into effect," Rob said, adding that their revenue has dropped by 80%.

According to him, they had to tighten their belts, reduce the size of their team, and postpone certain development plans for several months.

"It also affected our financing round. We were about to close our next round, but that was delayed since the VC is rebalancing their portfolio," added the co-founder of eParkio, which is on a mission to improve and simplify the experience of parking.

With eParkio, drivers get access to real-time info on parking spaces around them. (Photo credit: eParkio)
With eParkio, drivers get access to real-time info on parking spaces around them. (Photo credit: eParkio)

Despite the strain put on their startup, Rob says they have managed to keep things under control.

"Since we're a startup and work as a team, we were able to talk to each of the members and they all understood that there are certain things that need to be done for helping the startup survive. So sacrifices were made on all the fronts."

Rob Kramer, co-founder at eParkio (Photo credit: Via News)

Future of European Startups

Elaborating further on prospects for European startups, Rob said the impact of the current health crisis will be less severe in Europe than in the United States or China because the startup ecosystem in Europe was not "overheating" and the funding rounds were not very large.

He maintains that investors in Europe are more "conservative" and "look at a startup 1,500 times before they invest".

"In other countries—let's say in the U.S.—deals are done way faster. You can have your financing round closed in one, two, or three months depending on your size and your network, whereas in Europe it can take sometimes even up to nine months. So the investors were more risk-averse… They were protecting themselves so they didn't invest in too risky startups."

The impact of the current health crisis is expected to be less severe in Europe than in the United States or China.

Rob Kramer, CEO and co-founder at eParkio

The CEO of eParkio says startups should actively find ways to survive because investments are expected to drop further.

"But there is a correction coming, and new startups and new VCs will come out of this. Looking back in history, there's always been two steps forward, one step back. Currently, we are in the 'one step back' phase. But we will make the two steps forward—maybe not this year but in 2021 because this year overall there will be a huge dip in investment and obviously in the size of the economies in Europe and globally."

Big Winners

Rob says e-commerce is one of the big winners of this crisis because everything is moving online and e-commerce sales are through the roof.

Delivery and online payment services are seeing a surge in demand, he added, noting that the pandemic will speed up the move to online services.

"It is a good thing in a way since we should have all been there by now. A lot of the European economies will now start catching up."

In Rob's view, the outbreak will lead European countries where cash is still widely used to make a faster transition to online payment because "cash is dirty as a lot of people touch it, while online the payment is a more hygienic and faster way of conducting business."

Asked how he would describe the world after the coronavirus, the co-founder of eParkio said he is an "optimist" and prefers to describe it in a positive light.

"Let's call it a beautiful new world," he noted, expressing hope that the current chapter in history will open up new horizons.   

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com